stockrowNeogen Corporation
NEOG Healthcare Medical Devices
Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025.
- Revenue
- +6.50%
- EPS
- −129.4%
- Free cash flow
- +135.6%
- Total debt
- −2.31%
Quarter to August 2026, against a year earlier
Follow NEOG
Alert me
Neogen Corporation (NEOG) Gross margin
Neogen Corporation's gross margin over the twelve months to 31 August 2026 was 47.4%, up 0.5 percentage points from fiscal 2026 (46.9%). Over the past ten years it has ranged from 45.9% (fiscal 2021) to 50.2% (fiscal 2024); the current reading is higher than 42% of that period. That is below the Medical Devices industry median of 57.8% and below the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2026 | 46.9% | (0.17) |
| FY2025 | 47.1% | (3.09) |
| FY2024 | 50.2% | 0.83 |
| FY2023 | 49.4% | 3.26 |
| FY2022 | 46.1% | 0.19 |
| FY2021 | 45.9% | (1.03) |
| FY2020 | 46.9% | 0.60 |
| FY2019 | 46.3% | (0.47) |
| FY2018 | 46.8% | (0.34) |
| FY2017 | 47.2% | (0.49) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Aug 2026 | 47.4% | (0.50) |
| May 2026 | 47.9% | 0.97 |
| Feb 2026 | 46.9% | (0.60) |
| Nov 2025 | 47.5% | 2.07 |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| INSP Inspire Medical Systems, Inc. compare | 86.2% |
| AXGN AxoGen, Inc. compare | 74.2% |
| ESTA Establishment Labs Holdings Inc. compare | 70.5% |
| BFLY Butterfly Network, Inc. compare | 70.3% |
| TMDX TransMedics Group, Inc. compare | 58.6% |
| ALMR Alamar Biosciences, Inc. compare | 58.4% |
| NEOG Neogen Corporation | 47.4% |
| UFPT UFP Technologies, Inc. compare | 29.0% |
| ITGR Integer Holdings Corporation compare | 24.6% |
| Medical Devices industry median | 57.8% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on NEOG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement